Cellebrite (CLBT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Q1 2025 revenue grew 20% year-over-year to $107.5 million, driven by 21% subscription revenue growth and ARR expansion to $408 million, with adjusted EBITDA up 34% to $23.7 million (22% margin).
Subscription revenue accounted for 89% of total revenue, with strong growth in Americas, Asia-Pacific, and LATAM, offset by softness in U.S. federal and EMEA.
Over 30% of the install base migrated to Insights, on track for 50% by year-end; Guardian ARR grew over 100% year-over-year for the third consecutive quarter.
Hosted a sold-out user conference with 700 attendees from 27 countries and launched the Digital Justice Awards.
Announced new spring 2025 product release with cloud and AI-powered innovations, rebranding the platform as the Digital Investigation Platform.
Financial highlights
ARR reached $408 million, up 23% year-over-year, with gross retention steady at 92%.
Q1 revenue was $107.5 million, up 20% year-over-year, with subscription revenue at $95.8 million (21% growth), and 89% of revenue from subscriptions.
Non-GAAP gross margin was 84.4%, down 130 bps year-over-year due to higher hosting and customer success costs.
Adjusted EBITDA was $23.7 million (22% margin), up from 19.7% in Q1 2024.
Non-GAAP net income was $26.2 million ($0.10 per diluted share), with free cash flow of $18.5 million.
Cash, equivalents, and investments totaled $509.8 million at quarter-end, up $162.5 million year-over-year.
Outlook and guidance
Q2 ARR expected at $416–$426 million (20–23% growth); Q2 revenue guidance of $110–$116 million (15–21% growth); Q2 adjusted EBITDA expected at $26–$28 million (~24% margin).
Full-year 2025 ARR guidance maintained at $480–$495 million (21–25% growth); revenue guidance adjusted to $470–$485 million (17–21% growth); adjusted EBITDA at $113–$123 million (24–25% margin).
Full-year 2025 revenue guidance range reduced by $10 million at the low end due to timing of new business and lower one-time professional services revenue.
No change to full-year ARR and EBITDA guidance; majority of ARR and EBITDA expected in the second half, consistent with historical seasonality.
Latest events from Cellebrite
- SaaS-driven investigative platform targets $1B growth via tech innovation, federal, and global expansion.CLBT
Bank of America Global Technology Conference 20259 Jul 2026 - Q3 revenue up 18% to $126M, ARR up 19%, and Corellium acquisition to boost future growth.CLBT
Q3 20258 Jul 2026 - Rapid platform adoption, AI-driven analytics, and upsell-led growth drive digital forensics leadership.CLBT
TD Cowen ’s 53rd Annual Technology, Media & Telecom Conference 20258 Jul 2026 - AI-powered analytics and new products drive growth and innovation in digital investigations.CLBT
Mizuho Technology Conference 202610 Jun 2026 - AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows.CLBT
Investor update10 Jun 2026 - AI-driven platform expansion and FedRAMP High unlock new growth and efficiency opportunities.CLBT
46th Annual William Blair Growth Stock Conference3 Jun 2026 - AI-powered platform and FedRAMP cloud drive growth and transformation in public safety.CLBT
TD Cowen's 54th Annual Technology, Media & Telecom Conference27 May 2026 - Q1 2026 saw 21% ARR growth, 19% revenue growth, and strong AI-driven innovation.CLBT
Q1 202619 May 2026 - AI-driven digital intelligence and cloud innovation fuel strong growth and federal momentum.CLBT
J.P. Morgan 54th Annual Global Technology, Media and Communications Conference18 May 2026